LIfT BioSciences News

LIfT successfully produces CAR-IMANs to further enhance alpha neutrophil cancer killing

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies from iPSCs

LIfT BioSciences announces data demonstrating potent killing of pancreatic cancer tumouroids

LIfT BioSciences announces breakthrough preclinical data demonstrating dual mode of action

LIfT BioSciences and Minaris Regenerative Medicine Enter into a Manufacturing Partnership

LIfT BioSciences investors increase investment in LIfT and Johnson and Johnson welcomes LIfT into JL

Alex Blyth's Interview about how LIfT came to be, and why we need to move on from mouse models

LIfT at The Rejuvenation Summit

N-LIfT shows potent cancer killing across multiple solid tumour types

N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid

LIfT BioSciences secures its largest financing to date with a further £5m

LIfT BioSciences & King’s College London embark on an exciting new collaboration

LIfT BioSciences N-LIfT Cell Therapy Successfully Infiltrates Pancreatic Tumours In-vivo

LIfT BioSciences secures a further round of funding for its game-changing innate cell therapy

LIfT BioSciences signals a new dawn in Cancer Therapy at The Prostate Cancer Foundation Retreat

LIfT BioSciences Wins the Support of The European Institute for Innovation & Technology

LIfT BioSciences’ game-changing innate cell therapy for solid tumours gains backing of leading biote

LIfT BioSciences Wins BioVaria 2018

LIfT Bio successfully completes SEED fund raise

BBC Radio Interview on LIfT BioSciences